This site is intended for healthcare professionals only
LoginRegister
Novartis names Gilbert Ghostine as Chairman designate of Sandoz Board of DirectorsNovartis names Gilbert Ghostine as Chairman designate of Sandoz Board of Directors
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to...
SII to establish Dr Cyrus Poonawalla Centre of Excellence in Infectious Diseases and Pandemic Preparedness at HyderabadSII to establish Dr Cyrus Poonawalla Centre of Excellence in Infectious Diseases and Pandemic...
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA inspection: Cipla gets 8 observations for Pithampur facility
Zydus Lifesciences arm gets USFDA nod for Postherpetic Neuralgia drug GabapentinZydus Lifesciences arm gets USFDA nod for Postherpetic Neuralgia drug Gabapentin
Sun Pharma acquires DCGI approved anti-inflammatory brand Phlogam from Aksigen Hospital CareSun Pharma acquires DCGI approved anti-inflammatory brand Phlogam from Aksigen Hospital Care
CDSCO Panel Clears MSN Labs Abiraterone Acetate 1000 mg, Mandates Phase IV TrialMSN Lab gets CDSCO Panel nod for phase III CT of Elagolix Tablets
Merck gets USFDA priority review for PREVYMIS for Prophylaxis of Cytomegalovirus Disease in kidney transplant recipients at high riskMerck gets USFDA priority review for PREVYMIS for Prophylaxis of Cytomegalovirus Disease in kidney...
Pfizer, Valneva to stop Lyme disease vaccine trial in some patientsPfizer, Valneva to stop Lyme disease vaccine trial in some patients
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseModerna gets Health Canada authorization for Omicron-targeting bivalent COVID booster vaccine for 6...
Philips respiratory devices recall classified as most serious by USFDAPhilips respiratory devices recall classified as most serious by USFDA
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon recalls over 3000 bottles of antifungal drug Posaconazole Delayed Release in US
X